Alector presents preclinical data from al009 multi-siglec inhibitor program at the society for immunotherapy of cancer's 36th annual meeting

Preclinical oncology program highlights alector's expertise in harnessing components of the innate immune system to impact disease

ALEC Ratings Summary

ALEC Quant Ranking